Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8807 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.88 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8757 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD7074 |
Phase 3 |
0.8636 |
High Similarity |
NPD7472 |
Approved |
0.8629 |
High Similarity |
NPD3818 |
Discontinued |
0.8619 |
High Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.858 |
High Similarity |
NPD5844 |
Phase 1 |
0.858 |
High Similarity |
NPD7054 |
Approved |
0.8547 |
High Similarity |
NPD8313 |
Approved |
0.8547 |
High Similarity |
NPD8312 |
Approved |
0.8514 |
High Similarity |
NPD6166 |
Phase 2 |
0.8514 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8514 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8492 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8483 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8436 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8382 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8324 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8295 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8256 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8247 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8239 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8208 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8156 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8111 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8103 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8066 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8033 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7978 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7966 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7955 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7955 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7921 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7912 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.791 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.791 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7889 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7889 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7889 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7865 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7841 |
Intermediate Similarity |
NPD37 |
Approved |
0.7809 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7809 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7809 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7766 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7766 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7766 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7753 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7747 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7742 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7742 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7701 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7657 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7626 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7626 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7626 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7602 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7557 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7544 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7464 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7462 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7462 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7448 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7443 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7443 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7443 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7443 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7363 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7353 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7345 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7327 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7327 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7326 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7294 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7294 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7283 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7268 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7259 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7258 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7243 |
Intermediate Similarity |
NPD919 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7193 |
Intermediate Similarity |
NPD943 |
Approved |
0.7184 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7184 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7184 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7184 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7182 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7166 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7151 |
Intermediate Similarity |
NPD447 |
Suspended |
0.715 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7129 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7101 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7062 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7029 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7018 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7011 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7584 |
Approved |
0.6991 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6979 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6978 |
Remote Similarity |
NPD920 |
Approved |
0.6977 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6972 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD7930 |
Approved |
0.6932 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6927 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6273 |
Approved |
0.6911 |
Remote Similarity |
NPD5242 |
Approved |
0.6898 |
Remote Similarity |
NPD5353 |
Approved |
0.6893 |
Remote Similarity |
NPD5006 |
Approved |
0.6893 |
Remote Similarity |
NPD5005 |
Approved |
0.689 |
Remote Similarity |
NPD7585 |
Approved |
0.6879 |
Remote Similarity |
NPD3764 |
Approved |
0.6872 |
Remote Similarity |
NPD2800 |
Approved |
0.6872 |
Remote Similarity |
NPD1243 |
Approved |
0.686 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6856 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6854 |
Remote Similarity |
NPD2344 |
Approved |
0.6851 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD7583 |
Approved |
0.6839 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6836 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6809 |
Remote Similarity |
NPD4288 |
Approved |
0.6805 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6798 |
Remote Similarity |
NPD6099 |
Approved |
0.6798 |
Remote Similarity |
NPD6100 |
Approved |
0.6784 |
Remote Similarity |
NPD1203 |
Approved |
0.6782 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6782 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD2313 |
Discontinued |
0.678 |
Remote Similarity |
NPD4420 |
Approved |
0.678 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6765 |
Remote Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.6763 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6751
|
Remote Similarity |
NPD7038 |
Approved |